Pilot Study on Once Daily FTC, ddI, Efavirenz Combination in Antiretroviral Naive HIV Infected Adults

NCT00196599 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

39

Enrollment

OTHER_GOV

Sponsor class

Conditions

HIV Infections
Antiretroviral Naive

Interventions

DRUG: emtricitabine, FTC (drug)
DRUG: didanosine, ddI (drug)
DRUG: efavirenz (drug)

Sponsor

French National Agency for Research on AIDS and Viral Hepatitis

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]